Showing 7 of 7 recruiting trials for “hypereosinophilic-syndrome”
The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents
👨⚕️ Amy D Klion, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Feb 2025View details ↗
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
RecruitingNCT04538937 ↗
Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
👨⚕️ William E Shomali, MD, Stanford Cancer Institute Palo Alto📍 4 sites📅 Started Nov 2019View details ↗
RecruitingNCT04018118 ↗
Natural History of Hypereosinophilia and Hypereosinophilic Syndromes
RecruitingNCT00091871 ↗
A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
👨⚕️ Amy D Klion, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jun 2005View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →